Trial Profile
Oral medication using Tolvaptan for ADL of patients with acute congestive heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
- 13 Feb 2017 Status changed from recruiting to completed.
- 11 Mar 2014 New trial record